Zydus Lifesciences shares will be in focus on Wednesday after the company secured final approval from the US Food and Drug ...

New Delhi: Indian pharma major Zydus Lifesciences has entered into exclusive negotiations to acquire a majority stake in France-based orthopedic device maker Amplitude Surgical for up to €300 ...

Zydus Lifesciences Ltd. on Tuesday, March 11, said its board of directors approved the acquisition of 85.6% equity shares of Amplitude Surgical SA, France. In an exchange filing, the company said the ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

Zydus Lifesciences will acquire a majority stake in Amplitude Surgical, a European MedTech leader in lower-limb orthopaedic technologies, for €256.8 million. The acquisition will expand Zydus's ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus will focus on state-of-the-art manufacturing capabilities that will enable high quality solutions for patients with cutting-edge research and innovation, reports Financial Express.

Zydus Lifesciences on Monday said it has received approval from US health regulator USFDA to market a generic antifungal medication to treat dandruff, fungal infections, and other skin conditions. The ...

The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...

Completion of the transaction to be followed by mandatory simplified tender offer Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical ...